Signaling Mechanisms Underlying A&bgr; Toxicity: Potential Therapeutic Targets for Alzheimer's Disease

Publisher： Bentham Science Publishers

E-ISSN： 1996-3181|5|3|355-361

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.5, Iss.3, 2006-06, pp. : 355-361

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Amyloid &bgr;-Protein Precursor and Alzheimer's Disease. Therapeutic Approaches

By  

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 5, Iss. 4, 2005-12 ,pp. : 271-283

Bentham Science Publishers

Access to resources Recommend Favorite

Selective Modulation of A&bgr;42 Production in Alzheimer's Disease: Non-Steroidal Anti-Inflammatory Drugs and Beyond

By  

Current Pharmaceutical Design, Vol. 12, Iss. 33, 2006-11 ,pp. : 4337-4355

Bentham Science Publishers

Access to resources Recommend Favorite

Intracellular Amyloid &bgr;-Protein and Its Associated Molecules in the Pathogenesis of Alzheimer's Disease

By  

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 10, 2006-10 ,pp. : 1075-1080

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of &bgr;-Amyloid Protein in Synaptic Function: Implications for Alzheimer's Disease Therapy

By  

Current Neuropharmacology, Vol. 4, Iss. 2, 2006-04 ,pp. : 149-163

Bentham Science Publishers

Access to resources Recommend Favorite

&ggr;-Secretase as a Therapeutic Target for Treatment of Alzheimer's Disease

By  

Current Pharmaceutical Design, Vol. 12, Iss. 6, 2006-02 ,pp. : 661-670

Bentham Science Publishers

Access to resources Recommend Favorite